FCM Investments’s GSK GSK Stock Holding History

FCM Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$48K	Hold	1,080	–	–	0.07%	26
2017 Q3	$55K	Sell	1,080 -7,200	-87%	-$365K	0.07%	26
2017 Q2	$446K	Sell	8,280 -15,374	-65%	-$820K	0.34%	37
2017 Q1	$1.25M	Hold	23,654	–	–	0.79%	26
2016 Q4	$1.14M	Sell	23,654 -5,200	-18%	-$257K	0.69%	32
2016 Q3	$1.56M	Buy	28,854 +2,567	+10%	+$141K	0.87%	24
2016 Q2	$1.42M	Buy	26,287 +465	+2%	+$24.5K	0.85%	25
2016 Q1	$1.31M	Sell	25,822 -2,441	-9%	-$122K	0.7%	25
2015 Q4	$1.43M	Sell	28,263 -2,040	-7%	-$104K	0.74%	29
2015 Q3	$1.46M	Sell	30,303 -1,129	-4%	-$58.8K	0.72%	24
2015 Q2	$1.64M	Hold	31,432	–	–	0.78%	21
2015 Q1	$1.81M	Hold	31,432	–	–	0.88%	20
2014 Q4	$1.68M	Sell	31,432 -1,752	-5%	-$98K	0.79%	22
2014 Q3	$1.91M	Buy	33,184 +8,056	+32%	+$494K	0.87%	20
2014 Q2	$1.68M	Sell	25,128 -560	-2%	-$37.9K	0.77%	31
2014 Q1	$1.72M	Sell	25,688 -320	-1%	-$21.6K	0.71%	29
2013 Q4	$1.74M	Sell	26,008 -448	-2%	-$29K	0.71%	31
2013 Q3	$1.66M	Hold	26,456	–	–	0.67%	35
2013 Q2	$1.65M	Buy	+26,456	New	+$1.68M	0.74%	26

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FCM Investments's GSK Position: Q4 2017 in Review

FCM Investments held its GSK (GSK) position steady in Q4 2017 at 1,080 shares worth $48K. The position accounts for 0.07% of the portfolio, ranked #26.

FCM Investments first reported a position in GSK in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.91M in Q3 2014. 764 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

FCM Investments held 1,080 shares of GSK worth $48K as of Q4 2017.
FCM Investments left its GSK share count unchanged in Q4 2017.
GSK made up 0.07% of FCM Investments's portfolio in Q4 2017, its #26 holding.
FCM Investments first reported a position in GSK in Q2 2013 and has held it in 19 quarters since.
FCM Investments's GSK position peaked at $1.91M in Q3 2014.
764 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on FCM Investments's 13F filing for Q4 2017, filed 17 Jan 2018.